Dr. Ferrari is President and Chief Executive Officer of Houston Methodist Research Institute (HMRI), Executive Vice President of Houston Methodist Hospital System, and Senior Associate Dean and Professor of Medicine of Weill Cornell Medical College in New York. He has authored over 300 peer-reviewed publications, been granted over 25 patents, and been recognized with many national and international awards in oncology, engineering, drug delivery, and the pharmaceutical sciences. His exceptional record of funded research includes the leadership of several multi-investigator, multidisciplinary, and multi-institutional medical research centers funded by NCI, National Institute of General Medical Sciences, Defense Advanced Research Projects Agency, the Department of Defense, National Aeronautics and Space Administration, and the states of Texas and Ohio. The original developer of transport oncophysics, he is also considered one of the pioneers in nanomedicine and multiscale mechanics, both of which are central to the work in CITO. His areas of expertise comprise biophysics, semiconductor materials, mathematics, biomaterials, and nanotechnology for medicine, and his research aims to understand and leverage strategies for overcoming biological transport barriers to drugs and biological entities.
In addition to being Center PI, Dr. Ferrari also serves as one of four Administrative Core Co-Leaders and Leader of the Transport Oncophysics Core (TOC).